Chemfab Alkalis Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Chemfab Alkalis.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 20.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Here's What's Concerning About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital
Apr 04Market Might Still Lack Some Conviction On Chemfab Alkalis Limited (NSE:CHEMFAB) Even After 30% Share Price Boost
Feb 23Do Chemfab Alkalis' (NSE:CHEMFAB) Earnings Warrant Your Attention?
Jul 18Under The Bonnet, Chemfab Alkalis' (NSE:CHEMFAB) Returns Look Impressive
Feb 11Why We Like The Returns At Chemfab Alkalis (NSE:CHEMFAB)
Aug 30Be Wary Of Chemfab Alkalis (NSE:CHEMFAB) And Its Returns On Capital
May 10Some Investors May Be Worried About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital
Feb 02Does Chemfab Alkalis (NSE:CHEMFAB) Have A Healthy Balance Sheet?
Dec 20Returns On Capital Are Showing Encouraging Signs At Chemfab Alkalis (NSE:CHEMFAB)
Sep 27Increases to CEO Compensation Might Be Put On Hold For Now at Chemfab Alkalis Limited (NSE:CHEMFAB)
Jul 28Chemfab Alkalis (NSE:CHEMFAB) Is Doing The Right Things To Multiply Its Share Price
Jun 11Could Chemfab Alkalis Limited (NSE:CHEMFAB) Have The Makings Of Another Dividend Aristocrat?
Apr 19Is Chemfab Alkalis (NSE:CHEMFAB) Likely To Turn Things Around?
Feb 25Chemfab Alkalis (NSE:CHEMFAB) Has A Somewhat Strained Balance Sheet
Jan 18Three Things You Should Check Before Buying Chemfab Alkalis Limited (NSE:CHEMFAB) For Its Dividend
Dec 23What Do The Returns On Capital At Chemfab Alkalis (NSE:CHEMFAB) Tell Us?
Nov 27Are Chemfab Alkalis's (NSE:CHEMFAB) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 01We Think Chemfab Alkalis (NSE:CHEMFAB) Is Taking Some Risk With Its Debt
Sep 09Here’s What’s Happening With Returns At Chemfab Alkalis (NSE:CHEMFAB)
Aug 03Is Chemfab Alkalis Limited (NSE:CHEMFAB) A Good Fit For Your Dividend Portfolio?
Jul 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Chemfab Alkalis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 3,183 | 362 | N/A | N/A | N/A |
9/30/2023 | 3,159 | 440 | 118 | 694 | N/A |
6/30/2023 | 3,123 | 527 | N/A | N/A | N/A |
3/31/2023 | 3,314 | 646 | 350 | 926 | N/A |
12/31/2022 | 3,462 | 621 | N/A | N/A | N/A |
9/30/2022 | 3,400 | 592 | 606 | 808 | N/A |
6/30/2022 | 3,227 | 470 | N/A | N/A | N/A |
3/31/2022 | 2,716 | 287 | 347 | 549 | N/A |
12/31/2021 | 2,349 | 43 | N/A | N/A | N/A |
9/30/2021 | 2,034 | -66 | 340 | 413 | N/A |
6/30/2021 | 1,875 | -67 | N/A | N/A | N/A |
3/31/2021 | 1,808 | -81 | 381 | 454 | N/A |
12/31/2020 | 1,702 | 53 | N/A | N/A | N/A |
9/30/2020 | 1,753 | 96 | -199 | 424 | N/A |
6/30/2020 | 1,889 | 181 | N/A | N/A | N/A |
3/31/2020 | 2,045 | 254 | -80 | 542 | N/A |
12/31/2019 | 2,201 | 326 | N/A | N/A | N/A |
9/30/2019 | 2,126 | 336 | 36 | 567 | N/A |
6/30/2019 | 1,999 | 174 | N/A | N/A | N/A |
3/31/2019 | 1,932 | 168 | -120 | 410 | N/A |
12/31/2018 | 1,877 | 156 | N/A | N/A | N/A |
9/30/2018 | 1,892 | 162 | N/A | N/A | N/A |
6/30/2018 | 1,902 | 296 | N/A | N/A | N/A |
3/31/2018 | 1,796 | 255 | 177 | 439 | N/A |
3/31/2017 | 1,402 | 155 | N/A | 379 | N/A |
3/31/2016 | 248 | 4 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CHEMFAB's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if CHEMFAB's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if CHEMFAB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CHEMFAB's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if CHEMFAB's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CHEMFAB's Return on Equity is forecast to be high in 3 years time